Texas Biotechnology

TBC11251 (Sitaxsentan) Texas Biotechnology, USA ETA receptor Grade III PAH (designated orphan medicine in 2004)... 

Press releases by Revotar Biopharmaceuticals AG and Texas Biotechnology Corporation, February 6 and August 5, 2003. 

Texas Biotechnology Corp. (Asthma) The Automation Partnership The Genetics Company... 

Ribbons DW, SJC Taylor, CT Evans, SD Thomas, JT Rossiter, DA Widdowson, DJ Williams (1989) Biodegradations yield novel intermediates for chemical synthesis. In Biotechnology and Biodegradation (Eds D Kamely, A Chakrabarty, GS Omenn), pp. 213-245. Gulf Publishing Company, Houston, Texas. 

The other focus of biotechnology in intcrogravily is cell and tissue culturing experiments, Located at Johnson Space Flight Center in Houston. Texas, the goal of this research is to grow cells on a tissue in near-weightlessness. that otherwise is unachievable on Earth... 

Piletsky, S., Turner, A., (Eds) Molecular Imprinting of Polymers. Ill Series Biotechnology Intelligence Unit. Landes Bioscience. Georgetown, Texas, 2006... 

Another development occurring on the regulatory front is the activity at the state and local level. New Jersey, Texas California, Wisconsin, and North Carolina have all considered new or special approaches to biotechnology regulation, some with new legislation. In New Jersey, a moratorium measure was introduced in 1986, which later, as a compromise bill incorporating a review commission, passed unanimously in the state Senate. That bill is still waiting a vote in the New Jersey assembly. 

Kenneth H. Johnson (3), Baylor College of Medicine, Center for Biotechnology, The Woodlands, Texas 77381... 

David W. Hobson, Ph.D. Chrysalis Biotechnology, Inc., San Antonio, Texas,... 

Timothy K. Hayes Department of Entomology, Biotechnology Instrumentation Facility Peptide and Protein Technologies, Texas A M University, College Station, TX. Current Address Research and Development, Department of Bioanalytical Chemistry, Bayer Corporation, Clayton, NC... 

Cornerstone Pharmaceuticals, Cranbury, New Jersey and Stony Brook, New York Altira Capital and Consulting, LLC., Edison, New Jersey Center for Biotechnology, Stony Brook, New York Metabolic Research, Inc., Montgomery, Texas, USA and BrainStorm Cell Therapeutics,... 

D.A. Vattem Nutrition Biomedicine and Biotechnology, Texas State University, San Marcos, TX, USA, 78666. 

This work was supported by the National Science Foundation (CHE 9102657). The CFKR is supported jointly by the Biotechnology Research Resources Division of the NIH (RR00886) and by The University of Texas at Austin. 

Christelle Didier, Lille Catholic University, Erance Engineering ethics and science and technology studies Craig Hanks, Texas State University, U.S.A Continental approaches, pragmatism, environmental philosophy, biotechnology Byron Newberry, Baylor University, USA. 

Primary antibodies against DCX (e.g., Santa Cruz Biotechnology, Inc., Dallas, Texas), NeuroD (e.g., Santa Cruz Biotechnology, Inc.), and PH3 (e.g., Santa Cruz Biotechnology, Inc.). 

---